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Introduction Clinical pathways have been implemented in many healthcare systems with 
mix results in improving the quality of care and controlling the cost. CP is a 
methodology used for mutual decision making and organization of care for a 
well-defined group of patients within a well-defined period.
Methods In developing the CPs for a medical centre, several meetings had been carried 
out involving expert teams which consist of physicians, nurses, pharmacists 
and physiotherapists. The steps used to develop the pathway were divided 
into 5 phases. Phase 1: the introduction and team development, Phase II: 
determining the cases and information gathering, Phase III: establishing the 
draft of CP, Phase IV: is implementing and monitoring the effectiveness of 
CP while Phase V: evaluating, improving and redesigning of the CP.
Results Four CPs had been developed: Total Knee Replacement (TKR), ST Elevation 
Myocardial Infarction (AMI), Chronic Obstructive Airways Diseases 
(COAD) and elective Lower Segment Caesarean Section (LSCS). The 
implementation of these CPs had supported the evidence-based medicine, 
improved the multidisciplinary communication, teamwork and care planning. 
However, the rotation of posts had resulted in lack of document ownership, 
lack of direction and guidance from senior clinical staff, and problem of 
providing CPs prior to admission.
Conclusions The development and implementation of CPs in the medical centre improved 
the intra and inter departmental communication, improved patient outcomes, 
promote patient safety and increased patient satisfaction. However, 
accountability and understanding of the CPs must be given more attention.
Keywords Clinical pathway - quality of care - medical cost - evidence-based medicine -
multidisciplinary communication
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INTRODUCTION
In recent years, healthcare managers and 
organizations are facing intense pressures and 
challenges in minimising the cost of healthcare 
while maintaining its quality. As a result of this 
awareness, it has warranted healthcare managers, 
providers and healthcare organizations to explore 
ways and means to strategise and overcome these 
issues. 
One of the most recommended ways to 
deal with this issue is the introduction of Clinical 
Pathway (CP). It is a well documented and widely 
known tool that has been implemented with the 
objective to control the healthcare cost without 
compromising the quality.1-3 In healthcare services, 
CP has been proven to be able to reduce the cost 
and time spent in hospital while maintaining the 
best quality of services that can be offered to 
patients.3-10 
CP is a methodology used for mutual 
decision making and organization of care for a 
well-defined group of patients within a well-
defined period.11 The pathway can be elaborated as 
an integrated plan of care for group of patients with 
particular diagnosis designed to avoid delays, 
optimally utilize available resources and provide 
high quality of care that are based on the best 
clinical practice where multidisciplinary aspects are 
taken into account.1,12-13 The main objective of the 
CP is to enhance the quality of care and minimize 
cost incurred by improving patient outcomes, 
promoting patient safety, increasing patient 
satisfaction and optimizing the use of resources.11
Studies on the development and 
implementation of the CP are mostly carried out in 
the United States, Canada, Australia and the United 
Kingdom. Only a few studies are known to have 
been initiated in Asia, and we trust that our study is 
the first of its kind in Malaysia. Numerous studies 
have concluded that CP has its own pros and cons 
effects in healthcare system. Most of the studies on 
CP had shown positive impacts by reducing length 
of stay and medical cost. Several CPs have been 
developed and extensively used in the management 
of elective joints replacement,7-8,14-15 asthma in 
pediatric cases,16-17 management of uncomplicated 
acute myocardial infarction,2-5 management of 
congestive cardiac failure6,18-19 and management of 
pneumonia.20  
The intention of this article is to share the 
experience in developing and implementing CPs 
for ST Elevation Myocardial Infarction, Total Knee 
Replacement, elective Lower Segment Caesarean 
Section and Chronic Obstructive Airway Diseases
at UKMMC.
METHODS
A series of meetings and workshops comprising 
various team of experts were held while developing 
the CPs. They were the Cardiologists, Respiratory 
Physicians, Orthopaedic Surgeons, Obstetric & 
Gynaecologists, Public Health Medicine 
Specialists, Nurses, Pharmacists and 
Physiotherapists. The cases selected for 
development of CP was based on availability of the 
Clinical Practice Guidelines (CPG) in line with the 
best practices from literature reviews and experts 
consensus. In developing the CPs, our teams had 
incorporated the following seven steps:
1. Select an important area of practice 
The topic selection in general, 
concentrates on the homogenous care 
cases, high volume cases, high cost cases, 
interest from practitioners, and those cases 
with variations in practice that affect 
patients’ outcome. 
2. Gather support for the project
In order to incorporate CP into practice, 
the project must receive undivided support 
and agreement from the healthcare 
providers and managers. This is crucial for 
the successful implementation of the CP.
3. Form a multidisciplinary group / team
CP is a holistic approach in healthcare that 
involved multidisciplinary care. Active 
physicians’ participation and leadership is 
very critical to the development and 
implementation of the pathway. The lack 
of involvement of physicians has been 
cited as the main obstacle and cause of 
failure of the pathway.
4. Review practice and literature
Experts from various disciplines involved 
in managing the patients have to review 
current practices in comparison with best 
practices available in order to generate the 
CP. It is the result of collective effort by 
all team members.
5. Participation of local staff
Participation of local staff who is involved 
in providing the care is important. Their 
involvement should begin right from 
beginning by providing input on 
guidelines and local set up.
6. Development of the clinical pathway
All the specialists involved define the 
appropriate goals to satisfy the 
multidimensional needs of the patients. 
Results of the reviews are translated into 
elements of care detailed in local protocols 
and documentation, including the 
sequence of events and expected progress 
of patients over time.
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7. Pilot implementation of the clinical 
pathway 
CP implementation is very challenging 
and may cause a major problem if not 
handled properly. A very common 
anticipated problem is almost always the 
failure to follow the CP procedures. 
Concerns and misconceptions of the 
pathway are addressed through effective 
communication. 
The above steps are summarized in Table 
1. The suggested patient care process based on a 
time-task matrix is outlined in Gantt chart format. 
The list of care activities is along the vertical axis 
while timeline is along the horizontal axis. Clinical 
pathway includes components of expected 
outcomes and variance; in turn the care activities 
include assessments, investigations, medications, 
procedures, diets, referrals, educations and 
discharge planning. The timeline refers to location 
of patient and days while the outcome refers to the 
expected outcome of the treatment given to patient 
each day.
Table 1 General format of Clinical Pathway
                    TIME
ACTIVITIES
Day 1
Date:
Day 2 
Date:
Day 3
Date:
Day 4
Date:
Assessment
Investigations
Treatment
Medications
Diet
Teaching
Referral
Outcome
Discharge Plan
Note: X axis – timeline, Y axis - activities
Using the format as shown in Table 1, the 
teams managed to developed four CPs; ST 
Elevation Myocardial Infarction (STEMI), Total 
Knee Replacement (TKR), Elective Lower 
Segment Caesarean Section (LSCS) and Chronic 
Obstructive Pulmonary Diseases (COPD). Table 2 
and Table 3 show some of the activities that took 
place during the development of the TKR and 
COPD CPs. Each CP developed consists of 
detailed information on the roles and 
responsibilities of each healthcare providers 
involved in managing the cases; as illustrated in 
Table 4. Any care activities in the CP that is not in 
line with the expectations would be recorded as 
variance.21-22
Table 2 The Activities for Total Knee Replacement (TKR) Clinical Pathway 
Date :
CLINIC
Date :
PRE  OP  
Date:
OP  Day
Date:
POD 1
Date:
POD 2
Documentation 
& Assessment 
Indication                                          
for surgery
- Optimize 
medical 
problems  
- Note tracing 
- Pre & post Op 
Orientation      
- Nursing care          
planning
- Vital signs       
6Hrly 
Indication                                          
for surgery
Knee Score
- Optimize 
medical 
problems
- Templating
- Rule out local/ 
systemic   
infection
- Review Ix
- Nursing care
planning
- Vital signs 
post  op 
protocol
- APS chart 
- Circulation 
chart
- I/O chart 
- Drain chart
- Post op 
Wound 
assessment
- Nursing 
report
- Nursing care 
planning 
- Vital signs   
6Hrly
- Circulation 
chart 
- I/O chart
- Nursing 
report
- Nursing care
planning
- Vital signs 
6Hrly
- Circulation 
chart
- Wound
inspection 
and
Dressing
- Review 
Check X ray 
and blood 
result if any
- Nursing 
report
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- Consent
- Financial settle
Investigations - FBC
(OPTIONAL )
- RP 
(OPTIONAL )
- CXR
(OPTIONAL )
- ECG
(OPTIONAL )
- Knee X-rays
- FBC  
- RP
- RBS   
- Confirm GXM                                        
- CXR
- ECG 
- U-FEME
- Knee X rays
- C spine X ray 
- Post op Hb - Post op Knee 
X
rays
Table 3 Activities for Chronic Obstructive Airway Disease (COAD) Clinical Pathway (Day 1)
Activities Day 1
Assessment Chest assessment       Medical  history1        Clinical assessment  of severity1
           Done        (  )               Done        (  )                 Done        (  )
     Not done  (  )               Not done  (  )                 Not done  (  ) 
Observations Baseline vital signs then QID     Baseline SaO2 ( pulse oximetry ) then QID
           Done        (  )                                                      Done        (  )
     Not done  (  )                                                      Not done  (  ) 
Mental Health *select ONLY one
     Alert         (  )       Disorientated  (  )          Drowsy    (  )
Mobility ( filled up 
physiotherapist)
*select ONLY one
     Ambulant (  )    walks with assistance (  )     chair bound  (  )      
     Bed bound  (  )
Physiotherapy Chest assessment Exercise / education/advice      Chest physio (optional)
            Done        (  )                                                           Done        (  )
            Not done  (  )                                                           Not done  (  )
Oxygen Therapy O2 therapy         Yes   (  )    No     (  )
If Yes, Oxygen therapy (to maintain SaO2> 90%)
     Mask   (  )   Fio2: ___        OR                  Nasal prong  (  )   Fi02: ____   
Treatment 1. Bronchodilator therapy
 2-4 hourly  (More frequently if patient does not respond )
Yes (  )  No (  ) 
 Nebuliser ( air-driven)1 ml of Salbutamol (5mg/ml ) in 2 ml of normal saline
Yes (  )  No (  )                OR 
 MDI salbutamol 400 to 800 ug/day (through spacer)
Yes (  )  No (  )
 Add on ipratropium (if poor response), 1 ml of ipratropium 500mcg/2 ml
Yes (  )  No (  )
 Add IV Aminophylline 250mg/10 ml (if still not responding)
Yes (  )  No (  )
2. Corticosteroids
IV hydrocortisone  100 mg TDS
       Yes (  )  No (  )              OR
Oral Prednisolone 30mg  to 40 mg OD (total 7 - 14 days)
       Yes (  )  No (  )
3. Antibiotics 
 2 out of 3 cardinal symptoms : Increased dyspnoea, sputum volume and sputum 
purulence
 Total duration 7-10 days
       Azithromycin  IV / PO   (  )     OR     Erythromycin  IV / PO  (  )     PLUS
*Please select one
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      Amox/ clav  IV / PO  (  )   Cefuroxime  IV / PO (  )   Ceftriaxone  IV (  )   
Cefotaxime IV  (  )
     If  patient is at risk of Pseudomonas infection: Consider antipseudomonal 
treatment:
     Ciprofloxacin IV/PO  (  )   Cefepime IV  (  )   Tazocin® IV (  )     Others___:
4. Consider DVT prophylaxis SC heparin bd if patient bedridden > 4 days and age > 
50yo:
     If needed:    Yes  (  )  No   (  ),     If Yes,  Done (  )   Not done  (  )
Fluid therapy IVD regime, if needed   Yes  (  )   No   (  ),     Allow  Orally  (  )  NBM    (  )
Tests ABG:               Done  (  )  Not done  (  )  If  Yes, Room air (  )  oxygen (  )
ECG:               Done  (  )  Not done  (  )
Chest xray:      Done (  )  Not done  (  )
Renal Profile:  Done (  )  Not done  (  )
Full Blood Count:            Done  (  )  Not done  (  )
Random Blood Sugar:      Done  (  )  Not done  (  )
Consults/ referral Physiotherapy:                 Done  (  )  Not done  (  )
Patient education Ward orientation:             Done  (  )  Not done  (  )
Discharge plan Nursing discharge plan:   Done  (  ) Not Done  (  )
Table 4 Roles of healthcare provider in COPD clinical pathway
CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
CLINICAL PATHWAY
INCLUSION CRITERIA:
 Adult patients,  aged 12 years and above admitted to the medical wards with a clinical diagnosis 
of acute exacerbation of COPD
 They must not require ventilator support on admission
EXCLUSION CRITERIA:
 History of current diagnosis of co morbidities which contribute to the patient’s worsening 
symptoms. Examples are.
o Congestive cardiac failure
o Use of long term oxygen therapy >or = 15 hours/ day
o Underlying malignancy
o Active tuberculosis
o Known interstitial lung or pulmonary thromboembolic disease
HOW TO USE THE CLINICAL PATHWAY
1. This is a proactive tool to avoid delays in treatment and discharge. These are not orders, only a 
guide to usual orders.
2. Place the Clinical Pathway in the patient case note. All health care personal in charge of the 
patient should fill in the required part in the clinical pathway. Sticker each page of the Pathway.
3. COPD CP includes general assessment, observations, mental health record, mobility, 
physiotherapy, oxygen requirement, treatments, fluid therapy, tests, consultations, patient 
education assessment, and plan of discharge
4. PHYSICIANS/DOCTORS: need to fill up the general assessment, mental health record, 
oxygen requirement, treatment, consults/referral, patient disease knowledge in patient 
education part and plan of discharge.
5. NURSES: need to fill up observation part, ward orientation, fluid therapy, test, nurses 
discharge plan and arrangement of follow up date.
6. PHARMACIST: need to fill up pharmacist assessment in patient education part
7. PHYSIOTHERAPIST: need to fill up physiotherapy assessment part
8. A case manager will collect and ensure the collections are completed by the various health care 
personnel involved. This will be done on a daily basis.
9. Any deviation from the clinical pathway will be documented as a variance in a separate sheet.
Stick patient 
sticker here
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All patients admitted with the above 
diagnoses were screened and those who fullfilled 
the inclusion criterias were recruited into the study. 
All respondents were required to furnish written 
consent. Respondents were allowed to withdraw 
from the study at any time they so wish if they 
were to change their mind. Once recruited, the 
handout of clinical pathways was inserted to the 
case note. The clinical pathway commenced from 
the moment the respondents were diagnosed until 
they were discharged. 
RESULTS
A pilot study was done to implement the newly 
developed CPs of ST Elevation Myocardial 
Infarction (STEMI), Total Knee Replacement 
(TKR), Elective Lower Segment Caesarean Section 
(LSCS) and Chronic Obstructive Pulmonary 
Diseases (COPD). The implementation began in 
Mac 2009 until December 2010. The designated 
departments involved in implementing this CPs 
were Emergency Department, Coronary Care Unit, 
Medical, Orthopedic and Obstetric wards. 
Each CP team was tasked to educate and 
inform all doctors, nurses and other care providers 
who were not directly involved in the development 
of the pathway through a Continuous Medical 
Education (CME) program. They were briefed on 
the mission, goals and objectives of the CP, method 
of data collection and variance recording. The head 
nurse in each ward was appointed as the case 
manager, who would be responsible to document, 
coordinate, monitor and compile the entire CP. The 
case manager was also required to record any 
variance occurred in each CP using the variance 
sheet. The data and variance collected would then 
be analyzed by the researchers and physicians 
involved in the CP.
There were pros and cons in implementing 
the CP in the selected wards. On the positive note, 
the execution of CPs at these wards had lent 
support to the introduction of evidence-based 
medicine and use of clinical guidelines, improve 
multidisciplinary communication, teamwork and 
care planning, support training, maximize the 
efficient use of resources without compromising 
the quality of patient care. 
On the other side, there were some 
inevitable minor setbacks encountered while 
implementing the CPs. These setbacks such as the 
rotation of posts that led to lack of document 
ownership, lack of direction and guidance from 
senior clinical staff, CP patients were not provided 
with sufficient information prior to admission and
unrecorded variance, could have been avoided if 
only every detail was attended to. But these issues 
were and will be resolved as the study progressed 
to minimise the negative impact.
DISCUSSION
Clinical pathway was introduced in 1985. It is now 
being used in the United States, the United 
Kingdom and worldwide. We trust that we are the 
pioneers in developing and implementing the 
clinical pathway in Malaysia, certainly at 
UKMMC. Clinical pathway has been proven as an 
effective tool in healthcare management where 
patient care delivery can be improved and total 
healthcare cost can be controlled in developed 
countries. 
CP is beneficial and effective in 
improving healthcare management where every 
important step in patients’ care is examined and 
taken into account. However, a third of the articles 
reviewed concur that CP is not suitable to be 
applied and implemented on patients with 
complicated surgery and surgical illness.1-2, 16, 18. 
The clinical pathways for strokes and chronic renal 
failure patients had shown some unfavourable 
outcomes.10
In developing and implementing the CP, 
the team members were made up of case managers, 
physicians and other healthcare providers who 
were involved in managing the patients. Those 
involved in the study were expected to fully 
understand their roles and responsibilities; 
otherwise the clinical pathway application and 
implementation would not achieve its goals and 
objectives. Hence, empowerment of learning 
processes within an organization; intra- and inter-
department have been implemented in this study, as 
a result of which the professionals and supporting 
staff have better understanding on their roles and 
responsibilities. The empowerments of learning 
also promote integration in patients’ care in order 
to improve quality of care and reduce variations 
and substandard care. 
There were mixed responses during the 
application and implementation of the CPs. The 
CPs were excellent in improving patients 
management, able to support evidence-based 
medicine and clinical practice guidelines as 
described by doctors and physicians. The findings 
were in full agreement with other previous 
studies.3, 12-13, 23 Clinical pathways also improve 
multidiscipline communication (intra and inter-
department), commitment and teamwork – the 
three vital aspects in patients’ care. These positive 
findings were revealed in this study especially in 
STEMI and TKR CPs. Similar findings were 
reported in other studies.2-3, 7, 14, 23  
Further, the clinical pathways had proven 
to increase the level of awareness among doctors in 
cost control by avoiding unnecessary investigations 
and medications. Efficient resources utilization
without compromising the quality of patient care is 
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a positive note resulted from the implementation of 
CP; and other studies have also reported similar 
findings.1-3, 14, 23
However, there were also some setbacks 
encountered during the CPs implementation which 
required immediate solution. This study realized 
that most of the setbacks encountered were a 
misunderstanding in nature – among healthcare 
providers and supporting staff who were handling 
the CP. In one of the case, the nurses were the only 
members of the team who used the CP, while other 
healthcare providers did not. This was due to 
misunderstanding that CPs are for nurses only. It 
was also discovered that there was a lack of 
direction and guidance from senior clinical staff in 
two of the CPs implemented. Majority of the 
articles reviewed stated that the physicians and 
practitioners are the key players in any pathway 
development and implementation;1-3, 12-13, 23 and 
based on our own experience, we agree to that.
The study also detected that the CP form 
was not provided to the patient’s folder prior to 
admission, and the activities were not charted and 
recorded properly. The shortcoming was due to the 
patient’s admission in the early hours of the 
morning, weekend and public holidays. About one 
third of the CP forms was not properly documented 
and was not taken into account; otherwise we could 
have a bigger sample size. For this reason, our 
sample size was slightly smaller than anticipated; 
though the findings remain valid. Similar 
discoveries are also detected by other previous 
studies.3, 7, 23
Working in rotation among the healthcare 
providers and supporting staffs have also 
contributed to the non-continuity of the CPs usage. 
The CPs was often overlooked and the documents’ 
ownership among staff were also lacking. 
Responsibility and accountability of healthcare 
providers and supporting staff in using and 
implementing the CP is critical to the success of 
CP. These aspects were part of missing and 
incomplete data documentation and recording; 
fortunately the number was too small to disturb and 
offset our findings.
CONCLUSIONS
As a tertiary hospital, it has developed, launched, 
and implemented the clinical pathways for ST 
Elevation Myocardial Infarction, Total Knee 
Replacement, Elective Lower Segment Caesarean 
Section and Chronic Obstructive Pulmonary 
Diseases. And we trust that this study is the first of 
its kind in Malaysia. There are obvious pros and 
cons in its application and implementation. 
Nevertheless, in order to attain better results, the 
hospital should anticipate, identify, co-ordinate and 
monitor the application and progress of the CPs 
regularly, consistently and rigorously. Additional 
analysis and evaluation will be carried out to assess 
its effectiveness in controlling the medical cost and 
to further improve the quality of care.
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